board of directors GA4GH Incorporates as a Not-For-Profit Organization in Canada As a formal not-for-profit, the group is able to raise funds from private entities and enter into formal contracts as it positions itself as an international standards organization. Qlucore Expands Into Diagnostics, Precision Medicine With New Informatics Offering Premium The new Qlucore Diagnostics software builds on the recently updated Qlucore Omics Explorer platform, initially to help clinicians diagnose and treat leukemia. Lone Star Withdraws Effort to Replace Enzo Board Members After ISS Supports Firm's Candidates The investment firm had sought to place two candidates on Enzo's board but withdrew its proxy contest after failing to gain ISS's endorsement. UPDATE: Investment Firm Agitates for Change in Enzo Biochem's Board The Enzo shareholder issued an open letter stating its concern about the company's stock performance. Epic Sciences Raises $30M in Private Financing; Lucier Named Chairman NEW YORK (GenomeWeb) – Epic Sciences has raised $30 million in a Series C round of private financing that it will use to support development of its circulating tumor cell analysis platform. Mar 27, 2013 Dissident Shareholder Goggin Wins Seat on Vermillion's Board of Directors Mar 11, 2013 Proxy Advisory Firm Suggests Vermillion Shareholders Elect Dissident Shareholder to Board Feb 14, 2013 Nanosphere's Revenues Double as Firm Names New CEO; Stock Plummets Nov 28, 2012 Genetic Technologies Names New Chairman, Acting CEO Nov 27, 2012 Genetic Technologies CEO, Others Resign Following Annual Meeting Jul 3, 2012 Pressure BioSciences Aims to Raise $1.2M in Private Placement May 15, 2012 Bruker Disagrees with ISS Recommendation on Board Vote Apr 18, 2012 Roche Won't Extend Offer for Illumina as Shareholders Re-elect Flatley, Others to Board Apr 17, 2012 Analyst: Illumina Shareholders Unlikely to Vote for Roche Offer, but Options Remain Apr 10, 2012 Third Proxy Firm Favors Re-election of Illumina Board Members over Roche Candidates Apr 6, 2012 ISS Recommends Illumina Shareholders Vote Against Roche's Nominees for Board Apr 2, 2012 Illumina Rejects Roche's Latest Offer Mar 20, 2012 Roche Files Proxy, Sends Letter to Illumina Shareholders Mar 19, 2012 Illumina Sets April 18 Date for Shareholder Meeting with Roche Proposal at Stake Feb 29, 2012 Vermillion Shareholders Seek Change in Board Members Jan 31, 2012 Roche Names Proposed Board Nominees for Illumina Nov 23, 2011 Response Biomedical Inks C$2M Debt Financing Pact Sep 15, 2011 Horizon Discovery Raises $18.6M in Series C Round Sep 17, 2010 Response Genetics Settles Proxy Contest; Revises Slate of Board Nominees Apr 5, 2010 Fund Seeks New Board Members for Orchid Cellmark Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.